查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1867543

DNA定序：全球市場佔有率和排名、總收入和需求預測（2025-2031年）

DNA Sequencing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 108 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球DNA定序市場預計在2024年達到237.28億美元，預計到2031年將達到698.63億美元，在預測期（2025-2031年）內以16.4%的複合年成長率成長。

DNA定序是用於確定DNA分子內核苷酸（A、T、C和G）序列的核心技術。透過對基因組進行全面分析，該技術能夠揭示個體遺傳突變和疾病相關突變。主要平台包括次世代定序（NGS）和第三代定序（TGS），它們具有高通量、高準確性和擴充性優勢。 DNA定序的應用領域十分廣泛，涵蓋疾病診斷、精準癌症治療、生殖醫學、微生物學、農業育種及法醫學。它是支撐精準醫療、生物製藥研發和生物資訊產業發展的基礎技術，正在革新生命科學研究的模式。

全球對精準醫療、生物多樣性研究和個人化醫療保健的需求日益成長，這主要得益於政府加大對公共衛生和疾病預防的投入、定序成本大幅下降、人工智慧和雲端運算提升了分析效率，以及液態生物檢體和無創產前檢測（NIPT）等高成長應用的快速普及。此外，法規環境的日趨成熟也加速了這些技術的商業化。

儘管技術不斷創新，DNA定序產業仍面臨諸多挑戰，包括原料價格波動、資料安全合規、智慧財產權壁壘以及臨床解讀不一致等。高階定序平台高度依賴穩定的供應鏈，而晶片和酵素等關鍵組件往往被少數供應商壟斷，使其極易受到地緣政治動盪的影響。已開發地區已推出嚴格的基因隱私法規，給全球服務供應商帶來了合規負擔。中國等新興市場在先進檢測服務的報銷和臨床應用方面也面臨許多限制。

在癌症篩檢、罕見疾病診斷、出生缺陷預防和生殖醫學等高附加價值領域，針對特定疾病的客製化解決方案的需求日益成長。製藥公司和合約研究組織（CRO）對全基因測序和單細胞定序的需求也在快速成長，推動了人工智慧診斷技術和伴隨診斷（CDx）平台的整合。各國有關人類遺傳資源管理的法規正在推動區域資料庫的建立和生態系統的強化。在不久的將來，定序資料將成為醫療決策和藥物研發的基礎，並催生資料即服務（DaaS）和基因組雲端平台等新型經營模式。

本報告旨在對全球DNA定序市場進行全面分析，重點關注總收入、市場佔有率和主要企業的排名，還包括按地區/國家、類型和應用進行的DNA定序分析。

DNA定序市場規模、估算和預測以銷售收入為指標，以2024年為基準年，並包含2020年至2031年的歷史數據和預測數據。我們運用定量和定性分析，幫助讀者制定業務/成長策略，評估市場競爭格局，分析自身在當前市場中的地位，並就DNA定序做出明智的商業決策。

市場區隔

公司

  • Illumina
  • Thermo Fisher Scientific
  • Eurofins Scientific
  • BGI
  • Natera
  • Berry Genomics
  • Roche
  • Novo Gene
  • MGI-Tech
  • LabCorp
  • Pacific Biosciences
  • Azenta Life Sciences
  • Oxford Nanopore
  • Macrogen

按類型分類的細分市場

  • 第一代DNA定序
  • 第二代DNA定序
  • 第三代DNA定序

應用領域

  • 學術研究
  • 臨床研究
  • 醫院和診所
  • 製藥和生物技術
  • 其他

按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 韓國
    • 東南亞
    • 印度
    • 澳洲
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 荷蘭
    • 北歐國家
    • 其他歐洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • 土耳其
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東和非洲地區

The global market for DNA Sequencing was estimated to be worth US$ 23728 million in 2024 and is forecast to a readjusted size of US$ 69863 million by 2031 with a CAGR of 16.4% during the forecast period 2025-2031.

DNA Sequencing is a core technology used to determine the order of nucleotides (A, T, C, G) in a DNA molecule. By comprehensively analyzing genomes, this technology reveals individual genetic variations and disease-related mutations. The dominant platforms include Next-Generation Sequencing (NGS) and Third-Generation Sequencing (TGS), which offer high throughput, precision, and scalability. DNA sequencing is widely applied in disease diagnosis, cancer precision medicine, reproductive health, microbiology, agricultural breeding, and forensic science. It has become a foundational driver for the advancement of precision medicine, biopharmaceutical R&D, and the bioinformatics industry, profoundly transforming the research paradigm in life sciences.

With growing global demand for precision medicine, biodiversity research, and personalized healthcare. Key drivers include increased government funding in public health and disease prevention, dramatic reductions in sequencing costs, enhanced interpretation efficiency enabled by AI and cloud computing, and the rapid adoption of high-growth applications such as liquid biopsy and non-invasive prenatal testing (NIPT). Regulatory environments are also maturing, facilitating faster commercialization.

Despite continuous technological advancements, the DNA sequencing industry faces notable challenges, including raw material price volatility, data security compliance, IP barriers, and inconsistencies in clinical interpretation. High-end sequencing platforms heavily depend on stable supply chains, with critical components such as chips and enzymes monopolized by a few suppliers, making them vulnerable to geopolitical disruptions. In developed regions, stricter legislation on genetic privacy introduces compliance burdens for global service providers. Emerging markets like China also face constraints in terms of reimbursement systems and clinical adoption pathways for advanced testing services.

In high-value application areas like cancer screening, rare disease diagnostics, birth defect prevention, and reproductive health, downstream demand is shifting toward customized solutions tailored to specific diseases. Demand for whole-genome and single-cell sequencing is also rising rapidly among pharmaceutical companies and CROs, driving convergence with AI-enabled diagnostics and CDx platforms. National regulations on human genetic resource management are propelling local database initiatives and ecosystem upgrades. In the foreseeable future, sequencing data will become the foundation of medical decision-making and drug discovery, fueling new business models such as Data-as-a-Service (DaaS) and genomic cloud platforms.

This report aims to provide a comprehensive presentation of the global market for DNA Sequencing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of DNA Sequencing by region & country, by Type, and by Application.

The DNA Sequencing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DNA Sequencing.

Market Segmentation

By Company

  • Illumina
  • Thermo Fisher Scientific
  • Eurofins Scientific
  • BGI
  • Natera
  • Berry Genomics
  • Roche
  • Novo Gene
  • MGI-Tech
  • LabCorp
  • Pacific Biosciences
  • Azenta Life Sciences
  • Oxford Nanopore
  • Macrogen

Segment by Type

  • First Generation DNA Sequencing
  • Second Generation DNA Sequencing
  • Third Generation DNA Sequencing

Segment by Application

  • Academic Research
  • Clinical Research
  • Hospitals and Clinics
  • Pharmaceuticals and Biotechnology
  • Other

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of DNA Sequencing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of DNA Sequencing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of DNA Sequencing in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 DNA Sequencing Product Introduction
  • 1.2 Global DNA Sequencing Market Size Forecast (2020-2031)
  • 1.3 DNA Sequencing Market Trends & Drivers
    • 1.3.1 DNA Sequencing Industry Trends
    • 1.3.2 DNA Sequencing Market Drivers & Opportunity
    • 1.3.3 DNA Sequencing Market Challenges
    • 1.3.4 DNA Sequencing Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global DNA Sequencing Players Revenue Ranking (2024)
  • 2.2 Global DNA Sequencing Revenue by Company (2020-2025)
  • 2.3 Key Companies DNA Sequencing Manufacturing Base Distribution and Headquarters
  • 2.4 Key Companies DNA Sequencing Product Offered
  • 2.5 Key Companies Time to Begin Mass Production of DNA Sequencing
  • 2.6 DNA Sequencing Market Competitive Analysis
    • 2.6.1 DNA Sequencing Market Concentration Rate (2020-2025)
    • 2.6.2 Global 5 and 10 Largest Companies by DNA Sequencing Revenue in 2024
    • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA Sequencing as of 2024)
  • 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 First Generation DNA Sequencing
    • 3.1.2 Second Generation DNA Sequencing
    • 3.1.3 Third Generation DNA Sequencing
  • 3.2 Global DNA Sequencing Sales Value by Type
    • 3.2.1 Global DNA Sequencing Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global DNA Sequencing Sales Value, by Type (2020-2031)
    • 3.2.3 Global DNA Sequencing Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Academic Research
    • 4.1.2 Clinical Research
    • 4.1.3 Hospitals and Clinics
    • 4.1.4 Pharmaceuticals and Biotechnology
    • 4.1.5 Other
  • 4.2 Global DNA Sequencing Sales Value by Application
    • 4.2.1 Global DNA Sequencing Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global DNA Sequencing Sales Value, by Application (2020-2031)
    • 4.2.3 Global DNA Sequencing Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

  • 5.1 Global DNA Sequencing Sales Value by Region
    • 5.1.1 Global DNA Sequencing Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global DNA Sequencing Sales Value by Region (2020-2025)
    • 5.1.3 Global DNA Sequencing Sales Value by Region (2026-2031)
    • 5.1.4 Global DNA Sequencing Sales Value by Region (%), (2020-2031)
  • 5.2 North America
    • 5.2.1 North America DNA Sequencing Sales Value, 2020-2031
    • 5.2.2 North America DNA Sequencing Sales Value by Country (%), 2024 VS 2031
  • 5.3 Europe
    • 5.3.1 Europe DNA Sequencing Sales Value, 2020-2031
    • 5.3.2 Europe DNA Sequencing Sales Value by Country (%), 2024 VS 2031
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific DNA Sequencing Sales Value, 2020-2031
    • 5.4.2 Asia Pacific DNA Sequencing Sales Value by Region (%), 2024 VS 2031
  • 5.5 South America
    • 5.5.1 South America DNA Sequencing Sales Value, 2020-2031
    • 5.5.2 South America DNA Sequencing Sales Value by Country (%), 2024 VS 2031
  • 5.6 Middle East & Africa
    • 5.6.1 Middle East & Africa DNA Sequencing Sales Value, 2020-2031
    • 5.6.2 Middle East & Africa DNA Sequencing Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions DNA Sequencing Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions DNA Sequencing Sales Value, 2020-2031
  • 6.3 United States
    • 6.3.1 United States DNA Sequencing Sales Value, 2020-2031
    • 6.3.2 United States DNA Sequencing Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States DNA Sequencing Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe DNA Sequencing Sales Value, 2020-2031
    • 6.4.2 Europe DNA Sequencing Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe DNA Sequencing Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China DNA Sequencing Sales Value, 2020-2031
    • 6.5.2 China DNA Sequencing Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China DNA Sequencing Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan DNA Sequencing Sales Value, 2020-2031
    • 6.6.2 Japan DNA Sequencing Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan DNA Sequencing Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea DNA Sequencing Sales Value, 2020-2031
    • 6.7.2 South Korea DNA Sequencing Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea DNA Sequencing Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia DNA Sequencing Sales Value, 2020-2031
    • 6.8.2 Southeast Asia DNA Sequencing Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia DNA Sequencing Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India DNA Sequencing Sales Value, 2020-2031
    • 6.9.2 India DNA Sequencing Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India DNA Sequencing Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Illumina
    • 7.1.1 Illumina Profile
    • 7.1.2 Illumina Main Business
    • 7.1.3 Illumina DNA Sequencing Products, Services and Solutions
    • 7.1.4 Illumina DNA Sequencing Revenue (US$ Million) & (2020-2025)
    • 7.1.5 Illumina Recent Developments
  • 7.2 Thermo Fisher Scientific
    • 7.2.1 Thermo Fisher Scientific Profile
    • 7.2.2 Thermo Fisher Scientific Main Business
    • 7.2.3 Thermo Fisher Scientific DNA Sequencing Products, Services and Solutions
    • 7.2.4 Thermo Fisher Scientific DNA Sequencing Revenue (US$ Million) & (2020-2025)
    • 7.2.5 Thermo Fisher Scientific Recent Developments
  • 7.3 Eurofins Scientific
    • 7.3.1 Eurofins Scientific Profile
    • 7.3.2 Eurofins Scientific Main Business
    • 7.3.3 Eurofins Scientific DNA Sequencing Products, Services and Solutions
    • 7.3.4 Eurofins Scientific DNA Sequencing Revenue (US$ Million) & (2020-2025)
    • 7.3.5 Eurofins Scientific Recent Developments
  • 7.4 BGI
    • 7.4.1 BGI Profile
    • 7.4.2 BGI Main Business
    • 7.4.3 BGI DNA Sequencing Products, Services and Solutions
    • 7.4.4 BGI DNA Sequencing Revenue (US$ Million) & (2020-2025)
    • 7.4.5 BGI Recent Developments
  • 7.5 Natera
    • 7.5.1 Natera Profile
    • 7.5.2 Natera Main Business
    • 7.5.3 Natera DNA Sequencing Products, Services and Solutions
    • 7.5.4 Natera DNA Sequencing Revenue (US$ Million) & (2020-2025)
    • 7.5.5 Natera Recent Developments
  • 7.6 Berry Genomics
    • 7.6.1 Berry Genomics Profile
    • 7.6.2 Berry Genomics Main Business
    • 7.6.3 Berry Genomics DNA Sequencing Products, Services and Solutions
    • 7.6.4 Berry Genomics DNA Sequencing Revenue (US$ Million) & (2020-2025)
    • 7.6.5 Berry Genomics Recent Developments
  • 7.7 Roche
    • 7.7.1 Roche Profile
    • 7.7.2 Roche Main Business
    • 7.7.3 Roche DNA Sequencing Products, Services and Solutions
    • 7.7.4 Roche DNA Sequencing Revenue (US$ Million) & (2020-2025)
    • 7.7.5 Roche Recent Developments
  • 7.8 Novo Gene
    • 7.8.1 Novo Gene Profile
    • 7.8.2 Novo Gene Main Business
    • 7.8.3 Novo Gene DNA Sequencing Products, Services and Solutions
    • 7.8.4 Novo Gene DNA Sequencing Revenue (US$ Million) & (2020-2025)
    • 7.8.5 Novo Gene Recent Developments
  • 7.9 MGI-Tech
    • 7.9.1 MGI-Tech Profile
    • 7.9.2 MGI-Tech Main Business
    • 7.9.3 MGI-Tech DNA Sequencing Products, Services and Solutions
    • 7.9.4 MGI-Tech DNA Sequencing Revenue (US$ Million) & (2020-2025)
    • 7.9.5 MGI-Tech Recent Developments
  • 7.10 LabCorp
    • 7.10.1 LabCorp Profile
    • 7.10.2 LabCorp Main Business
    • 7.10.3 LabCorp DNA Sequencing Products, Services and Solutions
    • 7.10.4 LabCorp DNA Sequencing Revenue (US$ Million) & (2020-2025)
    • 7.10.5 LabCorp Recent Developments
  • 7.11 Pacific Biosciences
    • 7.11.1 Pacific Biosciences Profile
    • 7.11.2 Pacific Biosciences Main Business
    • 7.11.3 Pacific Biosciences DNA Sequencing Products, Services and Solutions
    • 7.11.4 Pacific Biosciences DNA Sequencing Revenue (US$ Million) & (2020-2025)
    • 7.11.5 Pacific Biosciences Recent Developments
  • 7.12 Azenta Life Sciences
    • 7.12.1 Azenta Life Sciences Profile
    • 7.12.2 Azenta Life Sciences Main Business
    • 7.12.3 Azenta Life Sciences DNA Sequencing Products, Services and Solutions
    • 7.12.4 Azenta Life Sciences DNA Sequencing Revenue (US$ Million) & (2020-2025)
    • 7.12.5 Azenta Life Sciences Recent Developments
  • 7.13 Oxford Nanopore
    • 7.13.1 Oxford Nanopore Profile
    • 7.13.2 Oxford Nanopore Main Business
    • 7.13.3 Oxford Nanopore DNA Sequencing Products, Services and Solutions
    • 7.13.4 Oxford Nanopore DNA Sequencing Revenue (US$ Million) & (2020-2025)
    • 7.13.5 Oxford Nanopore Recent Developments
  • 7.14 Macrogen
    • 7.14.1 Macrogen Profile
    • 7.14.2 Macrogen Main Business
    • 7.14.3 Macrogen DNA Sequencing Products, Services and Solutions
    • 7.14.4 Macrogen DNA Sequencing Revenue (US$ Million) & (2020-2025)
    • 7.14.5 Macrogen Recent Developments

8 Industry Chain Analysis

  • 8.1 DNA Sequencing Industrial Chain
  • 8.2 DNA Sequencing Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 DNA Sequencing Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 DNA Sequencing Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. DNA Sequencing Market Trends
  • Table 2. DNA Sequencing Market Drivers & Opportunity
  • Table 3. DNA Sequencing Market Challenges
  • Table 4. DNA Sequencing Market Restraints
  • Table 5. Global DNA Sequencing Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global DNA Sequencing Revenue Market Share by Company (2020-2025)
  • Table 7. Key Companies DNA Sequencing Manufacturing Base Distribution and Headquarters
  • Table 8. Key Companies DNA Sequencing Product Type
  • Table 9. Key Companies Time to Begin Mass Production of DNA Sequencing
  • Table 10. Global DNA Sequencing Companies Market Concentration Ratio (CR5 and HHI)
  • Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA Sequencing as of 2024)
  • Table 12. Mergers & Acquisitions, Expansion Plans
  • Table 13. Global DNA Sequencing Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 14. Global DNA Sequencing Sales Value by Type (2020-2025) & (US$ Million)
  • Table 15. Global DNA Sequencing Sales Value by Type (2026-2031) & (US$ Million)
  • Table 16. Global DNA Sequencing Sales Market Share in Value by Type (2020-2025)
  • Table 17. Global DNA Sequencing Sales Market Share in Value by Type (2026-2031)
  • Table 18. Global DNA Sequencing Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 19. Global DNA Sequencing Sales Value by Application (2020-2025) & (US$ Million)
  • Table 20. Global DNA Sequencing Sales Value by Application (2026-2031) & (US$ Million)
  • Table 21. Global DNA Sequencing Sales Market Share in Value by Application (2020-2025)
  • Table 22. Global DNA Sequencing Sales Market Share in Value by Application (2026-2031)
  • Table 23. Global DNA Sequencing Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 24. Global DNA Sequencing Sales Value by Region (2020-2025) & (US$ Million)
  • Table 25. Global DNA Sequencing Sales Value by Region (2026-2031) & (US$ Million)
  • Table 26. Global DNA Sequencing Sales Value by Region (2020-2025) & (%)
  • Table 27. Global DNA Sequencing Sales Value by Region (2026-2031) & (%)
  • Table 28. Key Countries/Regions DNA Sequencing Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 29. Key Countries/Regions DNA Sequencing Sales Value, (2020-2025) & (US$ Million)
  • Table 30. Key Countries/Regions DNA Sequencing Sales Value, (2026-2031) & (US$ Million)
  • Table 31. Illumina Basic Information List
  • Table 32. Illumina Description and Business Overview
  • Table 33. Illumina DNA Sequencing Products, Services and Solutions
  • Table 34. Revenue (US$ Million) in DNA Sequencing Business of Illumina (2020-2025)
  • Table 35. Illumina Recent Developments
  • Table 36. Thermo Fisher Scientific Basic Information List
  • Table 37. Thermo Fisher Scientific Description and Business Overview
  • Table 38. Thermo Fisher Scientific DNA Sequencing Products, Services and Solutions
  • Table 39. Revenue (US$ Million) in DNA Sequencing Business of Thermo Fisher Scientific (2020-2025)
  • Table 40. Thermo Fisher Scientific Recent Developments
  • Table 41. Eurofins Scientific Basic Information List
  • Table 42. Eurofins Scientific Description and Business Overview
  • Table 43. Eurofins Scientific DNA Sequencing Products, Services and Solutions
  • Table 44. Revenue (US$ Million) in DNA Sequencing Business of Eurofins Scientific (2020-2025)
  • Table 45. Eurofins Scientific Recent Developments
  • Table 46. BGI Basic Information List
  • Table 47. BGI Description and Business Overview
  • Table 48. BGI DNA Sequencing Products, Services and Solutions
  • Table 49. Revenue (US$ Million) in DNA Sequencing Business of BGI (2020-2025)
  • Table 50. BGI Recent Developments
  • Table 51. Natera Basic Information List
  • Table 52. Natera Description and Business Overview
  • Table 53. Natera DNA Sequencing Products, Services and Solutions
  • Table 54. Revenue (US$ Million) in DNA Sequencing Business of Natera (2020-2025)
  • Table 55. Natera Recent Developments
  • Table 56. Berry Genomics Basic Information List
  • Table 57. Berry Genomics Description and Business Overview
  • Table 58. Berry Genomics DNA Sequencing Products, Services and Solutions
  • Table 59. Revenue (US$ Million) in DNA Sequencing Business of Berry Genomics (2020-2025)
  • Table 60. Berry Genomics Recent Developments
  • Table 61. Roche Basic Information List
  • Table 62. Roche Description and Business Overview
  • Table 63. Roche DNA Sequencing Products, Services and Solutions
  • Table 64. Revenue (US$ Million) in DNA Sequencing Business of Roche (2020-2025)
  • Table 65. Roche Recent Developments
  • Table 66. Novo Gene Basic Information List
  • Table 67. Novo Gene Description and Business Overview
  • Table 68. Novo Gene DNA Sequencing Products, Services and Solutions
  • Table 69. Revenue (US$ Million) in DNA Sequencing Business of Novo Gene (2020-2025)
  • Table 70. Novo Gene Recent Developments
  • Table 71. MGI-Tech Basic Information List
  • Table 72. MGI-Tech Description and Business Overview
  • Table 73. MGI-Tech DNA Sequencing Products, Services and Solutions
  • Table 74. Revenue (US$ Million) in DNA Sequencing Business of MGI-Tech (2020-2025)
  • Table 75. MGI-Tech Recent Developments
  • Table 76. LabCorp Basic Information List
  • Table 77. LabCorp Description and Business Overview
  • Table 78. LabCorp DNA Sequencing Products, Services and Solutions
  • Table 79. Revenue (US$ Million) in DNA Sequencing Business of LabCorp (2020-2025)
  • Table 80. LabCorp Recent Developments
  • Table 81. Pacific Biosciences Basic Information List
  • Table 82. Pacific Biosciences Description and Business Overview
  • Table 83. Pacific Biosciences DNA Sequencing Products, Services and Solutions
  • Table 84. Revenue (US$ Million) in DNA Sequencing Business of Pacific Biosciences (2020-2025)
  • Table 85. Pacific Biosciences Recent Developments
  • Table 86. Azenta Life Sciences Basic Information List
  • Table 87. Azenta Life Sciences Description and Business Overview
  • Table 88. Azenta Life Sciences DNA Sequencing Products, Services and Solutions
  • Table 89. Revenue (US$ Million) in DNA Sequencing Business of Azenta Life Sciences (2020-2025)
  • Table 90. Azenta Life Sciences Recent Developments
  • Table 91. Oxford Nanopore Basic Information List
  • Table 92. Oxford Nanopore Description and Business Overview
  • Table 93. Oxford Nanopore DNA Sequencing Products, Services and Solutions
  • Table 94. Revenue (US$ Million) in DNA Sequencing Business of Oxford Nanopore (2020-2025)
  • Table 95. Oxford Nanopore Recent Developments
  • Table 96. Macrogen Basic Information List
  • Table 97. Macrogen Description and Business Overview
  • Table 98. Macrogen DNA Sequencing Products, Services and Solutions
  • Table 99. Revenue (US$ Million) in DNA Sequencing Business of Macrogen (2020-2025)
  • Table 100. Macrogen Recent Developments
  • Table 101. Key Raw Materials Lists
  • Table 102. Raw Materials Key Suppliers Lists
  • Table 103. DNA Sequencing Downstream Customers
  • Table 104. DNA Sequencing Distributors List
  • Table 105. Research Programs/Design for This Report
  • Table 106. Key Data Information from Secondary Sources
  • Table 107. Key Data Information from Primary Sources

List of Figures

  • Figure 1. DNA Sequencing Product Picture
  • Figure 2. Global DNA Sequencing Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global DNA Sequencing Sales Value (2020-2031) & (US$ Million)
  • Figure 4. DNA Sequencing Report Years Considered
  • Figure 5. Global DNA Sequencing Players Revenue Ranking (2024) & (US$ Million)
  • Figure 6. The 5 and 10 Largest Companies in the World: Market Share by DNA Sequencing Revenue in 2024
  • Figure 7. DNA Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 8. First Generation DNA Sequencing Picture
  • Figure 9. Second Generation DNA Sequencing Picture
  • Figure 10. Third Generation DNA Sequencing Picture
  • Figure 11. Global DNA Sequencing Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 12. Global DNA Sequencing Sales Value Market Share by Type, 2024 & 2031
  • Figure 13. Product Picture of Academic Research
  • Figure 14. Product Picture of Clinical Research
  • Figure 15. Product Picture of Hospitals and Clinics
  • Figure 16. Product Picture of Pharmaceuticals and Biotechnology
  • Figure 17. Product Picture of Other
  • Figure 18. Global DNA Sequencing Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 19. Global DNA Sequencing Sales Value Market Share by Application, 2024 & 2031
  • Figure 20. North America DNA Sequencing Sales Value (2020-2031) & (US$ Million)
  • Figure 21. North America DNA Sequencing Sales Value by Country (%), 2024 VS 2031
  • Figure 22. Europe DNA Sequencing Sales Value, (2020-2031) & (US$ Million)
  • Figure 23. Europe DNA Sequencing Sales Value by Country (%), 2024 VS 2031
  • Figure 24. Asia Pacific DNA Sequencing Sales Value, (2020-2031) & (US$ Million)
  • Figure 25. Asia Pacific DNA Sequencing Sales Value by Region (%), 2024 VS 2031
  • Figure 26. South America DNA Sequencing Sales Value, (2020-2031) & (US$ Million)
  • Figure 27. South America DNA Sequencing Sales Value by Country (%), 2024 VS 2031
  • Figure 28. Middle East & Africa DNA Sequencing Sales Value, (2020-2031) & (US$ Million)
  • Figure 29. Middle East & Africa DNA Sequencing Sales Value by Country (%), 2024 VS 2031
  • Figure 30. Key Countries/Regions DNA Sequencing Sales Value (%), (2020-2031)
  • Figure 31. United States DNA Sequencing Sales Value, (2020-2031) & (US$ Million)
  • Figure 32. United States DNA Sequencing Sales Value by Type (%), 2024 VS 2031
  • Figure 33. United States DNA Sequencing Sales Value by Application (%), 2024 VS 2031
  • Figure 34. Europe DNA Sequencing Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. Europe DNA Sequencing Sales Value by Type (%), 2024 VS 2031
  • Figure 36. Europe DNA Sequencing Sales Value by Application (%), 2024 VS 2031
  • Figure 37. China DNA Sequencing Sales Value, (2020-2031) & (US$ Million)
  • Figure 38. China DNA Sequencing Sales Value by Type (%), 2024 VS 2031
  • Figure 39. China DNA Sequencing Sales Value by Application (%), 2024 VS 2031
  • Figure 40. Japan DNA Sequencing Sales Value, (2020-2031) & (US$ Million)
  • Figure 41. Japan DNA Sequencing Sales Value by Type (%), 2024 VS 2031
  • Figure 42. Japan DNA Sequencing Sales Value by Application (%), 2024 VS 2031
  • Figure 43. South Korea DNA Sequencing Sales Value, (2020-2031) & (US$ Million)
  • Figure 44. South Korea DNA Sequencing Sales Value by Type (%), 2024 VS 2031
  • Figure 45. South Korea DNA Sequencing Sales Value by Application (%), 2024 VS 2031
  • Figure 46. Southeast Asia DNA Sequencing Sales Value, (2020-2031) & (US$ Million)
  • Figure 47. Southeast Asia DNA Sequencing Sales Value by Type (%), 2024 VS 2031
  • Figure 48. Southeast Asia DNA Sequencing Sales Value by Application (%), 2024 VS 2031
  • Figure 49. India DNA Sequencing Sales Value, (2020-2031) & (US$ Million)
  • Figure 50. India DNA Sequencing Sales Value by Type (%), 2024 VS 2031
  • Figure 51. India DNA Sequencing Sales Value by Application (%), 2024 VS 2031
  • Figure 52. DNA Sequencing Industrial Chain
  • Figure 53. DNA Sequencing Manufacturing Cost Structure
  • Figure 54. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 55. Bottom-up and Top-down Approaches for This Report
  • Figure 56. Data Triangulation
  • Figure 57. Key Executives Interviewed